Literature DB >> 17917049

X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update.

Donn M Stewart1, Lan Tian, Luigi D Notarangelo, David L Nelson.   

Abstract

X-linked hypogammaglobulinemia and isolated growth hormone deficiency (XLH-GHD, OMIM # 307200) is a primary immunodeficiency disorder characterized by pan-hypogammaglobulinemia and isolated growth hormone deficiency. The disease, which is only known to occur in a single family, shares many features with X-linked agammaglobulinemia (XLA, OMIM # 300300). The current review summarizes the clinical, laboratory and genetic features of the disease as they have unfolded over the past quarter century since its description.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17917049     DOI： 10.1007/s12026-007-0052-9

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   4.505


  29 in total

1.  RefSeq and LocusLink: NCBI gene-centered resources.

Authors:  K D Pruitt; D R Maglott
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia.

Authors:  C M Wilfert; R H Buckley; T Mohanakumar; J F Griffith; S L Katz; J K Whisnant; P A Eggleston; M Moore; E Treadwell; M N Oxman; F S Rosen
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

3.  A comprehensive genetic map of the human genome based on 5,264 microsatellites.

Authors:  C Dib; S Fauré; C Fizames; D Samson; N Drouot; A Vignal; P Millasseau; S Marc; J Hazan; E Seboun; M Lathrop; G Gyapay; J Morissette; J Weissenbach
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

4.  X-linked hypogammaglobulinemia and isolated growth hormone deficiency.

Authors:  T A Fleisher; R M White; S Broder; S P Nissley; R M Blaese; J J Mulvihill; G Olive; T A Waldmann
Journal:  N Engl J Med       Date:  1980-06-26       Impact factor: 91.245

5.  Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition.

Authors:  T Kouro; K Nagata; S Takaki; S Nisitani; M Hirano; M I Wahl; O N Witte; H Karasuyama; K Takatsu
Journal:  Int Immunol       Date:  2001-04       Impact factor: 4.823

6.  Colorectal cancer in patients with X-linked agammaglobulinaemia.

Authors:  J W van der Meer; R S Weening; P T Schellekens; I P van Munster; F M Nagengast
Journal:  Lancet       Date:  1993-06-05       Impact factor: 79.321

7.  X-linked agammaglobulinemia and gastric adenocarcinoma.

Authors:  P Lavilla; A Gil; M C Rodríguez; M L Dupla; V Pintado; G Fontán
Journal:  Cancer       Date:  1993-09-01       Impact factor: 6.860

8.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors:  D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

9.  Lymphocyte analysis in a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency after development of echovirus dermatomyositis and meningoencephalitis.

Authors:  D K Wagner; G E Marti; E S Jaffe; S E Straus; D L Nelson; T A Fleisher
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

10.  Regulation of an early developmental checkpoint in the B cell pathway by Ig beta.

Authors:  S Gong; M C Nussenzweig
Journal:  Science       Date:  1996-04-19       Impact factor: 47.728
View more
  1 in total

Review 1.  X-linked Agammaglobulinemia.

Authors:  Deepti Suri; Amit Rawat; Surjit Singh
Journal:  Indian J Pediatr       Date:  2016-02-24       Impact factor: 5.319
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.